IPAR vs PFE · P/E 17, rev $1.32B vs P/E 20, rev $62.58B
Inter Parfums Inc (IPAR) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported IPAR revenue for 2023-12-31 was $1.32B. Net income was $187.8M. Revenue was up 21.3% from 2022-12-31 to 2023-12-31. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
IPAR currently screens at market cap $2.92B and trailing P/E 17.3. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the IPAR and PFE stock pages for the full models.
Not investment advice.